학술논문
A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma
Document Type
Article
Author
Kim, C.G.; Hong, M.H.; Kim, H.; Kim, G.; Lee, J.E.; Kim, C.; Kim, H.R.; Kim, D.; Kim, S.-H.; Hong, H.J.; Park, Y.M.; Sim, N.S.; Koh, Y.W.; Lee, B.H.; Kelly, G.; Kim-Schulze, S.; Merad, M.; Bang, Y.J.; Kim, H.J.; Ock, C.-Y.; Kang, M.; Song, H.; Oum, C.; Kim, S.; Kim, S.; Lim, Y.; Park, H.; Park, J.W.; Yoon, S.O.; Lee, C.G.; Kim, K.H.; Park, G.; Jung, I.; Han, D.; Kim, J.H.; Cha, J.; Lee, I.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 May 2024, 30(10):2097-2110)
Subject
Language
English
ISSN
15573265
10780432
10780432